Call us today for help! (214) 295-5011
“Our planet is at a turning point. The massive global migration underway now from countryside to cities will demand huge investments in energy, water, materials, waste, food distribution, and transportation over the next 25 years. If the right investments are made now, this unique opportunity will be the catalyst for dramatic changes . . .” …
The Prospective Netherland Cohort Study gathered data for more than 17 years on 58,279 Norwegian men between 55 and 69 years of age. The amount of asbestos exposure was estimated by linkage to job-exposure matrices. Purpose The study was to determine the association between asbestos exposure length and intensity as applied to contracting pleural mesothelioma, lung …
Eisai, and its subsidiary Morphotek, discovered and have developed an investigational monoclonal antibody amatuximab. This drug “has a high affinity and specificity for mesothelin, a protein which is overexpressed in people with malignant mesothelioma.” The European Commission has granted this antibody an orphan drug designation (ODD). This designation is for medicines developed for the diagnosis, …
Most people are aware that working with asbestos can cause serious, life-threatening health hazards such as lung cancer and mesothelioma decades after exposure. Some people are aware that disturbing asbestos in commercial and residential buildings while remodeling or tearing them down is also extremely dangerous. But few consider that disposing of asbestos materials carries its …
A study published on January 20, 2014 in the Journal of Thoracic Oncology, revealed that patients with epithelial mesothelioma responded well to pre-operative radiation in a specialized approach called SMART or Surgery for Mesothelioma After Radiation Therapy. This slower growing type of mesothelioma affects about 70 percent of mesothelioma patients. What is this new approach? …
